Could The Long Deckline In Biotechnology M&A Be Ending
There were at least 14 biopharma purchases totaling $50 million or more between April and June, which is at least twice as many as...
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
An innovative system for monitoring chromosomal fragility and copy number alterations in particularly lethal tumours was described earlier this July by researchers from Cambridge University...
Indian Pharma Business May Increase 8-11%, Predicts Alkem
When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on,...
Lonza To Construct $518mn Fill-Finish Plant In Switzerland
Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the...
Deloitte Believes Mature R&D Firms Reap Enterprise Value
According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with...
Singapore Authorises New Ovarian Cancer Treatment By GSK
The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal...
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...